drugset / Trial / NCT00930566
Extracorporal Photopheresis Pilot Study
NaSingle-groupOpen-labelPrevention
Summary
ECP will be given to the patients \[UVAR®XTS TM Therakos system, Johnson \& Johnson\] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allowed it: 2 ECP per week the first 2 weeks, and 1 ECP per week during 1 month. Total = 8 ECP after transplantation.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methoxsalen | Other / unclassified | — | Other |